Type 3 Von Willebrand Disease clinical trials

Explore recruiting type 3 von willebrand disease clinical trials.

Recruiting type 3 von willebrand disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Type 3 Von Willebrand Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase III, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Emicizumab Prophylaxis in Patients with Type 3 Von Willebrand Disease

Belgium, Sweden, Spain, Germany, France, Netherlands +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Type 3 Von Willebrand Disease trials by city

Type 3 Von Willebrand Disease in Toronto Type 3 Von Willebrand Disease in Vancouver Type 3 Von Willebrand Disease in Montreal Type 3 Von Willebrand Disease in Calgary Type 3 Von Willebrand Disease in Edmonton Type 3 Von Willebrand Disease in Ottawa Type 3 Von Willebrand Disease in Winnipeg Type 3 Von Willebrand Disease in Quebec City Type 3 Von Willebrand Disease in Hamilton Type 3 Von Willebrand Disease in Kitchener Type 3 Von Willebrand Disease in London Type 3 Von Willebrand Disease in Halifax Type 3 Von Willebrand Disease in New York Type 3 Von Willebrand Disease in Los Angeles Type 3 Von Willebrand Disease in Chicago Type 3 Von Willebrand Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease